Fig. 1

Flowchart of study selection and design ^aAdditional records were identified from NEJM evidence (https://evidence.nejm.org/). AE indicates adverse event; ICI, immune checkpoint inhibitor; IO, immunotherapy; NSCLC, non-small cell lung cancer; RCT, randomized controlled trial; TEAE, treatment emergent adverse event; TRAE, treatment-related adverse event